Tanolux® 50 ug/ml - Glaucoma - Rx

Tanolux® 50 ug/ml - Glaucoma - Rx
Product Description

Tanolux® Latanoprost 50 ug/ml, a well-known prostaglandin analogue eye drop, presented in single-dose vials using our Blow-Fill-Seal Technology.

  • Innovative format in single-dose vials
  • No cold chain required, easy to store & carry
  • Vey low solvents concentration vs other unit-dose latanoprost eye drops
  • Sterile until opened
  • Sterilized by filtration without affecting the quality of the finished product
  • Good stability performance

Read more Show less

Laboratorios Salvat, S.A.

  • ES
  • 2016
    On CPHI since
  • 4
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Drug delivery device Supplier/Manufacturer
Licensee
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
Contract Manufacturer
Contract Research Organisation
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    Spain
More specifications Fewer specifications
Sales Markets
Show more Show less

Laboratorios Salvat, S.A.

  • ES
  • 2016
    On CPHI since
  • 4
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Drug delivery device Supplier/Manufacturer
Licensee
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
Contract Manufacturer
Contract Research Organisation
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile

More Products from Laboratorios Salvat, S.A. (21)

  • SVT-15473 - Inflammation and pain after ocular surgery - Clobetasol 0.05% nanoemulsion Rx

    Product SVT-15473 - Inflammation and pain after ocular surgery - Clobetasol 0.05% nanoemulsion Rx

    SVT-15473 is the first strongest ophthalmic corticosteroid formulated in nanoemulsion (nanodroplets below ~30nm), using IMPACT-SVT®, a patented drug delivery technology, and in single-dose vials, using Blow-Fill-Seal technology packaging.

    SVT-15473 has&nbs...
  • Clotic®- Otic Fungal Infection - Otic Rx

    Product Clotic®- Otic Fungal Infection - Otic Rx

    Clotic® is a broad-spectrum otic antimycotic agent effective against pathogenic dermatophytes, yeasts and several species of fungus, Well-recognized safety and efficacy.
    The first and only treatment with clinical evidence against otomycosis. Preservative-free.

    Indication: Otic fu...
  • Ophthalmic CDMO Services

    Product Ophthalmic CDMO Services

    Salvat offers the best services and solutions, drawing on a long history of expertise in developing and manufacturing successful medications.

    Tailored solutions to customer needs through our Ophthalmic platform: • • Customized solutions using Salvat's technology: suspensions, solutions, micellar,...
  • Contract Development & Manufacturing Services (CDMO)

    Product Contract Development & Manufacturing Services (CDMO)

    With 70 years of experience in developing and manufacturing pharmaceutical products for diverse markets, we excel in Operational Excellence, Flexibility, and Adaptability.

    Salvat offers integrated CDMO services with state-of-the-art manufacturing facilities in Barcelona, Madrid, and Miami, equip...
  • Blow-Fill-Seal Technology (BFS) Single-dose vials CDMO

    Product Blow-Fill-Seal Technology (BFS) Single-dose vials CDMO

    Salvat specializes in developing and manufacturing sterile liquid pharmaceutical products in single-dose vials using Blow-Fill-Seal (BFS) technology.

    Advantages of using Blow-Fill-Seal technology in your products: 
    • • Innovative format, providing differentiation for your produ...
  • Bimeox® 0.3mg/ml - Glaucoma (Preservative-free) - Rx

    Product Bimeox® 0.3mg/ml - Glaucoma (Preservative-free) - Rx

    Bimeox® Bimatoprost 0.3 mg/ml, a well-known prostaglandin analogue eye drop, preservative-free, presented in single-dose vials using our Blow-Fill-Seal Technology.

    • Innovative format in single-dose vials • Preservative-free for better tolerability • Sterile until ope...
  • Tebarat 0.5 mg/ml - Allergic conjunctivitis - single-dose vials eye drops - Rx

    Product Tebarat 0.5 mg/ml - Allergic conjunctivitis - single-dose vials eye drops - Rx

    Tebarat 0.5 mg/ml eye drops are indicated for the treatment and prevention of allergic conjunctivitis. Treatment and prevention of seasonal allergic conjunctivitis symptoms in adults and children aged 4 years and over.Treatment of non-seasonal (perennial) allergic conjunctivitis symptoms in adults and chil...
  • Relive® Sicca - Dry eye - Nanoemulsion eye drops - MD

    Product Relive® Sicca - Dry eye - Nanoemulsion eye drops - MD

    Symptomatic relief of moderate to severe dry eye syndrome, using IMPACT-SVT® nanoemulsion patent drug delivery technology. 

    Holistic approach for a multi-factorial pathology: anti-inflammatory, antioxidant, mucogenic, mucoadhesion, lubrication, and anti-evaporative activity. •...
  • Relive® Total Care - Lubrication + UV protection eye drops - MD

    Product Relive® Total Care - Lubrication + UV protection eye drops - MD

    Regenerate, protect against UV radiation, and lubricate. Eye tears, specially designed for after surgery.
    • 20 unit dose vials of 0,4 ml • Preservative free • With Actinoquinol 0,3%, Cyanocobalamin 0,05%, PVPK 30 1,5% 
  • Relive® - Day & Night eye drops - MD

    Product Relive® - Day & Night eye drops - MD

    RELIVE® DRY EYE - 8 Hours of Dry Eye Relief
    RELIVE® NIGHT - 12 Hours of Long-lasting Dry Eye Relief • Preservative-Free • Phosphate-Free • Single-dose vials, very Convenient format
  • Cetraxal® Plus 3mg/ml + 0.25 mg/ml - AOE & AOMT - Otic solution Rx

    Product Cetraxal® Plus 3mg/ml + 0.25 mg/ml - AOE & AOMT - Otic solution Rx

    Unique combination "ciprofloxacin 3 mg + Fluocinolone 0.25 mg" topical solution 

    Indication: Acute otitis externa and acute otitis media with perforated eardrums in adults and pediatric patients. 
    Dosage regimen: B.I.D x 7 days
    Presentation of multi-dose 10 ml and unit dose vials (14...
  • Ekzem® 0.25 mg/ml - Otic eczema - single-dose vials - otic solution Rx

    Product Ekzem® 0.25 mg/ml - Otic eczema - single-dose vials - otic solution Rx

    Fluocinolone acetonide, topical solution. Ekzem is indicated for the treatment of otic eczema in adults. Demonstrated efficacy and safety in clinical studies 
    Available in unit dose vials of 0.4 ml each. (30 vials x box)
show all 21 other products

Laboratorios Salvat, S.A. resources (2)

  • Laboratorios Salvat inicia un estudio pediátrico pionero en Europa con su fármaco innovador SVT-15473, para el tratamiento de la inflamación y dolor tras la cirugía ocular

    News Laboratorios Salvat inicia un estudio pediátrico pionero en Europa con su fármaco innovador SVT-15473, para el tratamiento de la inflamación y dolor tras la cirugía ocular

    • Los ensayos clínicos fase III realizados en adultos confirman la eficacia y el excelente perfil de seguridad de SVT-15473 clobetasol oftálmico, formulado con IMPACT-SVT® tecnología patentada de nanoemulsiones, para el tratamiento de la inflamación y el dolor después de una cirugía ocular.
    • Es el primer estudio clínico que se realiza en paciente pediátrico con un corticoide tópico oftálmico en toda Europa.
    • Con el nuevo estudio que se inicia ahora y que se llevará a cabo en seis hospitales españoles se espera demostrar también su seguridad en pacientes pediátricos de 0 a 3 años.
    • Con este proyecto, que ha supuesto una inversión global de más de 20 millones de euros, Laboratorios Salvat da un paso más en su estrategia de afianzarse como un actor clave en el área de oftalmología a nivel internacional.
    10 Jul 2023
  • SVT-15473 + IMPACT-SVT® Nanoemulsion technology

    Video SVT-15473 + IMPACT-SVT® Nanoemulsion technology

    Salvat has developed IMPACT-SVT®, a patented nanoemulsion drug delivery technology that improves drug mucus penetration and bio-adhesion, providing excellent ocular comfort.

    IMPACT-SVT® made it possible to develop SVT-15473, using the strongest corticosteroid in the global market.

    2023-11-22